Loading clinical trials...

Aripiprazole in Children and Adolescents With Chronic Tic Disorder or Tourette's Disorder | Clinical Trials | Clareo Health

Back to clinical trial search

COMPLETEDPhase 3NCT00706589

Aripiprazole in Children and Adolescents With Chronic Tic Disorder or Tourette's Disorder

The purpose of this trial is to demonstrate the efficacy and safety of aripiprazole in children and adolescents aged 6\~18 years with chronic tic disorders or Tourette's disorder

Lead sponsor: Korea Otsuka Pharmaceutical Co., Ltd.•6 locations•View source on ClinicalTrials.gov

Clareo plain-language summary

What this study is about

Generating AI summary...

Save this trial guide to your notes

Keep your clinical trial research organized — questions to ask, what to expect, and key details.

Related studies

COMPLETEDPhase 3

Efficacy & Safety Study of Once-weekly Oral Aripiprazole in Children and Adolescents With Tourette's Disorder

NCT01418339 · Tourette's Disorder

TERMINATEDPhase 4

Trial to Evaluate the Long-term Efficacy of Oral Aripiprazole in the Treatment of Pediatric Participants With Tourette's Disorder

NCT03661983 · Tourette's Disorder (TD)

COMPLETED

ABF Tourette's Disorder Post Marketing Surveillance Study

NCT01795105 · Tourette's Disorder

COMPLETEDNA

Internet-based Behaviour Therapy for Tourette's Disorder and Chronic Tic Disorder

NCT02864589 · Tourette's Disorder, Persistent (Chronic) Motor or Vocal Tic Disorder

COMPLETEDPhase 1/2

Proof-of-Concept Safety Study of CPP-109 (Vigabatrin) for Treatment Refractory Tourette's Disorder

NCT01585207 · Tourette's Disorder

View all related studies →

Data from ClinicalTrials.govLast updated on ClinicalTrials.gov: July 26, 2013Terms

Trial snapshot

StatusCOMPLETED

PhasePHASE3

Enrollment61

Start dateOct 2008

Last updatedJul 26, 2013

Condition

Chronic Motor or Vocal Tic Disorder Tourette's Disorder

Locations shown

Inha University Hospital

Inchon

Seoul National University Hospital

Seoul

Yonsei University Severance Hospital

Seoul

For caregivers

Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.

Start free trial →

Data Source & Attribution

This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.

ClinicalTrials.gov last update: July 26, 2013Data synced to Clareo: May 25, 2026

Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.

Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.

View ClinicalTrials.gov Terms and Conditions